Published in Int J Geriatr Psychiatry on September 01, 2008
Do positive or negative experiences of social support relate to current and future health? Results from the Doetinchem Cohort Study. BMC Public Health (2012) 1.01
Influence of social support on cognitive change and mortality in old age: results from the prospective multicentre cohort study AgeCoDe. BMC Geriatr (2012) 0.87
Social activity and cognitive functioning over time: a coordinated analysis of four longitudinal studies. J Aging Res (2012) 0.84
The Impact of Exercise, Cognitive Activities, and Socialization on Cognitive Function: Results From the National Long-Term Care Survey. Am J Alzheimers Dis Other Demen (2014) 0.82
Social Function and Cognitive Status: Results from a US Nationally Representative Survey of Older Adults. J Gen Intern Med (2016) 0.82
Social network characteristics and salivary cortisol in healthy older people. ScientificWorldJournal (2012) 0.80
Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study. BMC Public Health (2015) 0.80
The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research. J Neurosci Nurs (2014) 0.80
Social relationships and risk of incident mild cognitive impairment in U.S. Alzheimer's disease centers. Alzheimer Dis Assoc Disord (2014) 0.78
Mild cognitive impairment: searching for the prodrome of Alzheimer's disease. World Psychiatry (2008) 0.78
The importance of neighborhood ecological assets in community dwelling old people aging outcomes: A study in Northern Portugal. Front Aging Neurosci (2015) 0.77
Hearing, Cognition, and Healthy Aging: Social and Public Health Implications of the Links between Age-Related Declines in Hearing and Cognition. Semin Hear (2015) 0.76
Cognitive activity mediates the association between social activity and cognitive performance: A longitudinal study. Psychol Aging (2016) 0.75
Negative aspects of close relationships as risk factors for cognitive aging. Am J Epidemiol (2014) 0.75
Developmental Patterns of Cognitive Function and Associated Factors among the Elderly in Taiwan. Sci Rep (2016) 0.75
Physical Activity and Cognitive Function in Older Adults: The Mediating Effect of Depressive Symptoms. J Neurosci Nurs (2016) 0.75
Social Network Size and Cognitive Functioning in Middle-Aged Adults: Cross-Sectional and Longitudinal Associations. J Adult Dev (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 45.63
STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA (1963) 38.91
A scaled version of the General Health Questionnaire. Psychol Med (1979) 18.13
Leisure activities and the risk of dementia in the elderly. N Engl J Med (2003) 8.77
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med (1999) 5.39
Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc (1995) 3.51
Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry (1997) 3.48
Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47
Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. Health Psychol (2001) 2.69
Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med (2003) 2.57
Participating in social activities helps preserve cognitive function: an analysis of a longitudinal, population-based study of the elderly. Int J Epidemiol (2005) 2.17
Education and dementia. BMJ (1995) 1.90
Social network characteristics and cognition in middle-aged and older adults. J Gerontol B Psychol Sci Soc Sci (2004) 1.55
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2003) 3.79
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008) 3.48
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry (2004) 2.82
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol (2006) 2.71
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry (2005) 2.61
Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry (2002) 2.52
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry (2009) 2.16
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc (2004) 2.01
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry (2010) 1.83
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry (2011) 1.83
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry (2013) 1.80
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry (2015) 1.65
The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sex Transm Dis (2004) 1.65
Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am J Epidemiol (2002) 1.64
Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry (2015) 1.62
The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. J Am Med Dir Assoc (2008) 1.61
A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry (2011) 1.61
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry (2007) 1.50
Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med (2006) 1.48
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.47
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci (2008) 1.46
The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2004) 1.46
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc (2014) 1.35
Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging (2008) 1.35
Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.33
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist (2005) 1.30
Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry (2006) 1.24
Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study. J Gerontol A Biol Sci Med Sci (2005) 1.22
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement (2010) 1.20
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr (2012) 1.20
Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry (2003) 1.19
The incidence of mental and behavioral disturbances in dementia: the cache county study. J Neuropsychiatry Clin Neurosci (2003) 1.18
Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry (2011) 1.16
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry (2004) 1.13
Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Med (2010) 1.12
Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry (2011) 1.11
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement (2012) 1.11
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry (2010) 1.11
The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. J Neuroimaging (2011) 1.10
Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc (2005) 1.10
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis (2011) 1.10
The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. Am J Epidemiol (2013) 1.06
Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol (2011) 1.06
A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry (2004) 1.03
Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. Am J Geriatr Psychiatry (2012) 1.03
Correlates of caregiver-rated quality of life in assisted living: the Maryland Assisted Living study. J Gerontol B Psychol Sci Soc Sci (2006) 1.03
DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis (2011) 1.02
A clinical approach to mild cognitive impairment. Am J Psychiatry (2006) 1.02
Rapidly progressive dementias and the treatment of human prion diseases. Expert Opin Pharmacother (2010) 1.00
Antipsychotic drugs in dementia: what should be made of the risks? JAMA (2005) 0.99
Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study. Am J Geriatr Psychiatry (2013) 0.99
Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics (2003) 0.98
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'. Int J Geriatr Psychiatry (2005) 0.96
Apolipoprotein E genotype and lifetime cognitive decline. Int Psychogeriatr (2007) 0.95
Epidemiology, assessment, and treatment of dementia. Psychiatr Clin North Am (2011) 0.94
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma. J Alzheimers Dis (2010) 0.94
Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci (2003) 0.94
Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures. Qual Life Res (2011) 0.94
Predictors of providing informed consent or assent for research participation in assisted living residents. Am J Geriatr Psychiatry (2008) 0.94
Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. Int J Geriatr Psychiatry (2006) 0.94
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry (2012) 0.93
Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat (2012) 0.93
Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study. Int J Geriatr Psychiatry (2005) 0.93
MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts. Neurobiol Dis (2002) 0.92
Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study. Int Psychogeriatr (2012) 0.92
Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry (2012) 0.92
Predictors of caregiver unawareness and nontreatment of dementia among residents of assisted living facilities: the Maryland Assisted Living Study. Am J Geriatr Psychiatry (2006) 0.91
Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimers Dement (2008) 0.91
Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2012) 0.91
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)? Int J Geriatr Psychiatry (2011) 0.90
Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. Am J Geriatr Psychiatry (2005) 0.89
Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr (2008) 0.88
Searching for valid psychiatric phenotypes: discrete latent variable models. Int J Methods Psychiatr Res (2010) 0.88
Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease. J Alzheimers Dis (2011) 0.87
Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's disease. PLoS One (2010) 0.87
Psychiatric aspects of traumatic brain injury. Psychiatr Clin North Am (2002) 0.86
Amantadine for executive dysfunction syndrome in patients with dementia. Psychosomatics (2004) 0.86
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. J Gerontol B Psychol Sci Soc Sci (2011) 0.86